Roth Capital Affirms Sarepta (SRPT) at 'Buy'; Shapeshifting Bears Back to Where It Started Sep 3, 2015 09:32AM
Roth Capital Reiterates Buy on Performance Sports Group (PSG) Following Analyst and Investor Event Sep 3, 2015 09:02AM
Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals Sep 3, 2015 08:18AM
Roth Capital Reiterates Buy on Ligand Pharma (LGND) Following E.U. Approval of Promacta Sep 2, 2015 09:05AM
Ligand Pharma (LGND) Reaffirmed at 'Buy' by Roth Following European Promacta Approval, Evomela Update Sep 2, 2015 08:38AM
View Older Stories

Sep 2, 2015 08:26AM Roth Capital Cuts Price Target on Crossroads Systems (CRDS) Ahead of 3Q Results
Sep 1, 2015 09:41AM Roth Capital Reiterates Buy on Trevena (TRVN) Following TRV130’s Phase 2b Results
Sep 1, 2015 08:40AM Roth Capital Positive on SolarEdge (SEDG) Following Recent Investor Meetings
Sep 1, 2015 06:40AM Roth Updates Ests on Adept Technology (ADEP) Following Q4 Results, Outlook; Maintains 'Buy' Rating
Aug 28, 2015 12:07PM's Hot Lunchtime Reads 8/28: (GME) (GB) (FXI) (ADP)
Aug 28, 2015 11:45AM Roth Capital Trims Ests on Sky Solar (SKYS) Following Q2 Results; Sees Close to Securing Capital
Aug 28, 2015 07:45AM Roth Capital Re-Starts RMG Networks Holding (RMGN) at Buy
Aug 28, 2015 07:42AM Roth Capital Starts Cerulean Pharma (CERU) at Buy, $9 PT
Aug 27, 2015 09:46AM Applied Genetic Tech (AGTC) Triggers Enrollment Milestone in XLRS Phase I/II; Roth Affirms at 'Buy'
Aug 27, 2015 07:08AM Roth Capital Cuts Price target on Tilly's, Inc. (TLYS) to $12 Following EPS Beat
Aug 26, 2015 10:55AM Verastem (VSTM) Sell-Off 'Ignores Main Value Driver', Roth Capital Says
Aug 26, 2015 09:59AM Roth Capital Remains Bullish on SolarCity (SCTY) Following Investor Meetings
Aug 26, 2015 09:39AM SolarCity (SCTY) Remains 'Top Pick' at Roth Following Investor Meetings
Aug 26, 2015 06:55AM Roth Capital Sees Opportunity of Year-End Approval for Sarepta's (SRPT) Eteplirsen; PT Lifted to $50
Aug 25, 2015 09:28AM Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)
Aug 25, 2015 07:36AM Roth Capital Starts Quantum Corp. (QTM) at Buy
Aug 24, 2015 12:02PM's Hot Lunchtime Reads 8/24: (AAPL) (LGND) (MON) (FCAU)
Aug 24, 2015 11:51AM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Expanded Promacta Indication
Aug 24, 2015 08:15AM Roth Capital Positive on Peregrine Pharma (PPHM) Amid New Immunotherapy Collaboration (AZN)
Aug 24, 2015 07:26AM Roth Capital Cuts Price Target on Synergy Resources (SYRG) to Reflect New Oil Price Forecast.
Aug 21, 2015 11:10AM Notable Analyst Rating Changes 8/21: (SYMC) (CMPR) (CSIQ) Upgraded; (CPA) (LUX) (SSI) Downgraded
Aug 21, 2015 10:32AM Roth Capital Positive on BioBlast Pharma (ORPN) Following Q2 Report; H215 Should be Busy with Phase 3 Initiations
Aug 21, 2015 08:50AM Roth Capital Starts Hanwha Q CELLS (HQCL) at Buy
Aug 21, 2015 07:58AM GigOptix (GIG) Prices 9.22M Common Stock Offering at $1.70/Share
Aug 21, 2015 07:58AM GigOptix, Inc. Announces Pricing of Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions
Aug 20, 2015 04:26PM GigOptix (GIG) Announces Common Stock Offering
Aug 20, 2015 04:26PM GigOptix, Inc. Announces Proposed Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions
Aug 20, 2015 12:40PM Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following Q2 Results; BL-8040 Continues to be Main Driver
Aug 20, 2015 09:44AM Roth Remains Positive on VBL Therapeutics (VBLT) as VB-111 Phase 3 in rGBM Commences
Aug 20, 2015 09:04AM Palatin (PTN) 'Sitting Pretty' After Valeant/Sprout Deal - Roth Capital
Aug 20, 2015 09:02AM Palatin's (PTN) BMT Thesis Improves with Recent Sprout Pharma News - Roth Capital (VRX)
Aug 19, 2015 04:52PM xG Technology, Inc. Announces Closing of Public Offering
Aug 19, 2015 09:06AM Flibanserin Approval Seen as Positive Read-Thru for Sarepta Therapeutics (SRPT), Others - Roth Capital
Aug 19, 2015 08:57AM Roth Capital Raises Price target on Energy Focus (EFOI) to $23 Following Recent Volatility
Aug 19, 2015 08:24AM Roth Lifts PT on Energy Focus (EFOI) to $23; No Longer Overlooked in Broader Lighting Segment
Aug 19, 2015 08:17AM Roth Capital Cuts Price Target on Energy Fuels (UUUU) Following 2Q15 Results
Aug 19, 2015 08:00AM Telesta Therapeutics Closes US$28.6 Million Private Placement
Aug 19, 2015 07:58AM Palatin Technologies' (PTN) BMT Has Advantages Over Flibanserin, Says Roth
Aug 19, 2015 07:23AM Roth Capital Trims PT on Trina Solar (TSL) to $15; China Market Weakness Offsetting Module Strength
Aug 19, 2015 06:52AM Roth Capital Trims PT on Canadian Solar (CSIQ) Following Q2 Results, Outlook; Notes Yieldco Remains 'on Track'
Aug 18, 2015 11:06AM Roth Capital Affirms Omeros (OMER) at 'Buy' Following Quantified OMS721 Data; Longer-Term Needed for Soliris Comparison
Aug 18, 2015 09:16AM Roth Capital Cuts Price Target on Marathon Patent Group (MARA) Following 2Q EPS Miss
Aug 18, 2015 09:03AM Roth Capital Reiterates Buy on Quicklogic Corp (QUIK) Seeing Design Wins on Wearables
Aug 18, 2015 07:30AM Revel Systems, POS Industry Leader, Extends its Series C to $110 Million to Expand its Industry Leadership
Aug 17, 2015 03:28PM Roth Capital Remains Cautiously Optimistic on Spectrum Pharma (SPPI) Following Apaziquone Phase 3 SPA Agreement
Aug 17, 2015 10:20AM GPM Reminds Investors of the Upcoming Deadline in the Class Action on Behalf of Iconix Brand Group, Inc. Investors
Aug 17, 2015 09:48AM Roth Capital Positive on BioLineRx (BLRX) Following BL-8040 Phase 2b Initiation
Aug 17, 2015 08:00AM Roth Affirms Clean Diesel Tech (CDTI) at 'Buy'; Still Sees Cash Shortfall in Early-FY16
Aug 14, 2015 04:58PM Marathon Patent Group and Uniloc Agree to Merge
Aug 14, 2015 09:10AM xG Technology (XGTI) Prices Class A, B Units Public Offering
View Older Stories